Europe Dry Eye Syndrome Market Size, Share & COVID-19 Impact Analysis, By Product (Anti-inflammatory Products {Cyclosporin, Corticosteroids, and Others}, Artificial Tears and Lubricants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI107540

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Dry Eye Disease, by Key Countries, 2022
2. Key Industry Developments
3. New Product Launches
4. Reimbursement Policies
5. Regulatory Scenario
6. Healthcare Industry Overview, by Key Countries
7. Impact of COVID-19 on Global Dry Eye Syndrome Market
Europe Dry Eye Syndrome Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Competitive Analysis
1. Europe Market Share Analysis (2022)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. AbbVie Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  2. Alcon
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  3. Novartis AG
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  4. Santen Pharmaceutical Co., Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  5. OASIS Medical
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  6. Sun Pharmaceutical Industries Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  7. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings, Co., Ltd)
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  8. Sentiss Pharma Pvt. Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  9. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  10. VISUfarma
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Dry Eye Disease, by Key Countries, 2022
2. Key Industry Developments
3. New Product Launches
4. Reimbursement Policies
5. Regulatory Scenario
6. Healthcare Industry Overview, by Key Countries
7. Impact of COVID-19 on Global Dry Eye Syndrome Market
Europe Dry Eye Syndrome Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Competitive Analysis
1. Europe Market Share Analysis (2022)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. AbbVie Inc.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  2. Alcon
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  3. Novartis AG
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  4. Santen Pharmaceutical Co., Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  5. OASIS Medical
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  6. Sun Pharmaceutical Industries Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  7. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings, Co., Ltd)
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  8. Sentiss Pharma Pvt. Ltd.
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  9. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  10. VISUfarma
    1. Overview,
    2. Products,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Europe Dry Eye Syndrome Market Value (USD billion), by Product, 2022 & 2030

Figure 2: Europe Dry Eye Syndrome Market Value Share (%), by Product, 2022

Figure 3: Europe Dry Eye Syndrome Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 4: Europe Dry Eye Syndrome Market Value Share (%), by Distribution Channel, 2022

Figure 5: Europe Dry Eye Syndrome Market Value (USD billion), by Country/ Sub-Region, 2022 & 2030

Figure 6: Europe Dry Eye Syndrome Market Value Share (%), by Country/ Sub-Region, 2022

List of Tables

Table 1: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2019-2030

Table 2: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory, 2019-2030

Table 3: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 4: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2030

STUDY PERIOD: 2019-2030
BASE YEAR: 2022
HISTORICAL DATA: 2019-2021
NO OF PAGES: 109

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com